IL-4, IL-13, IL-22, and IL-17A can induce oxidative stress; hence, antioxidative AHR agonists, such as coal tar, glyteer, and tapinarof showed therapeutic efficacy for AD 197,198. Here, IL4 is linked to Alzheimer disease.